Pd. Jensen et al., HEART-TRANSPLANTATION IN A CASE OF JUVENILE HEREDITARY HEMOCHROMATOSIS FOLLOWED UP BY MRI AND ENDOMYOCARDIAL BIOPSIES, European journal of haematology, 51(4), 1993, pp. 199-205
Cardiac involvement in hereditary haemochromatosis (HH) is a poor prog
nostic sign and is the main cause of death in the juvenile form. The t
reatment of choice is iron removal therapy by phlebotomy, but treatmen
t by iron chelation (desferrioxamine) has been recommended in cases wi
th severe cardiac symptoms. We describe here the first case of juvenil
e HH undergoing heart transplantation, which became necessary despite
intensive iron removal therapy by phlebotomy and treatment by desferri
oxamine. Throughout the course the myocardial iron content was monitor
ed by endomyocardial biopsies and by magnetic resonance imaging (MRI).
At the last follow-up, 18 months after transplantation, the myocardia
l iron content in the transplanted heart was still within reference ra
nges by biochemical determination and MRI and the patient's condition
was completely satisfactory. In conclusion, heart transplantation shou
ld be considered in cases of severe juvenile HH. In the follow-up of t
hese patients MRI may be a useful supplement.